Celestica (NYSE:CLS - Get Free Report) TSE: CLS has been given a $450.00 price target by equities researchers at Royal Bank Of Canada in a research report issued on Wednesday,BayStreet.CA reports. The brokerage currently has an "outperform" rating on the technology company's stock. Royal Bank Of Canada's target price points to a potential upside of 45.73% from the company's previous close.
Several other brokerages have also recently weighed in on CLS. Weiss Ratings cut Celestica from a "buy (b)" rating to a "buy (b-)" rating in a research report on Thursday, August 13th. Bank of America reaffirmed a "buy" rating on shares of Celestica in a report on Wednesday, July 29th. TD Securities upgraded shares of Celestica from a "hold" rating to a "buy" rating and set a $430.00 target price on the stock in a research note on Wednesday, April 29th. TD Cowen raised shares of Celestica from a "hold" rating to a "buy" rating and raised their price target for the company from $350.00 to $430.00 in a report on Wednesday, April 29th. Finally, Wolfe Research upped their price target on shares of Celestica from $425.00 to $475.00 and gave the stock an "outperform" rating in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of $439.81.
Get Our Latest Research Report on CLS
Celestica Stock Performance
Celestica stock traded up $1.94 during mid-day trading on Wednesday, reaching $308.80. The company's stock had a trading volume of 651,085 shares, compared to its average volume of 2,445,446. The firm's fifty day moving average price is $337.47 and its two-hundred day moving average price is $335.71. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. Celestica has a 12-month low of $183.66 and a 12-month high of $474.02. The company has a market capitalization of $35.51 billion, a P/E ratio of 32.10 and a beta of 2.06.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, topping analysts' consensus estimates of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The firm had revenue of $4.68 billion during the quarter, compared to analyst estimates of $4.30 billion. During the same period last year, the company earned $1.39 earnings per share. The business's revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Sell-side analysts predict that Celestica will post 10.15 EPS for the current fiscal year.
Insider Activity at Celestica
In other news, CFO Mandeep Chawla sold 16,117 shares of the firm's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the sale, the chief financial officer owned 65,444 shares in the company, valued at approximately $24,169,778.08. This trade represents a 19.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Robert Mionis sold 23,496 shares of Celestica stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $362.39, for a total transaction of $8,514,715.44. Following the sale, the chief executive officer directly owned 23,396 shares of the company's stock, valued at $8,478,476.44. This represents a 50.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 356,553 shares of company stock valued at $135,238,444. 1.10% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Celestica
Several hedge funds have recently added to or reduced their stakes in CLS. Renaissance Technologies LLC bought a new position in Celestica during the 1st quarter valued at approximately $68,952,000. CIBC Asset Management Inc grew its stake in shares of Celestica by 7.7% in the fourth quarter. CIBC Asset Management Inc now owns 436,922 shares of the technology company's stock worth $129,499,000 after acquiring an additional 31,086 shares during the last quarter. Norges Bank bought a new position in shares of Celestica during the fourth quarter valued at $456,511,000. Marietta Investment Partners LLC purchased a new position in shares of Celestica in the 4th quarter worth about $1,273,000. Finally, BW Gestao de Investimentos Ltda. boosted its stake in Celestica by 29.9% in the 4th quarter. BW Gestao de Investimentos Ltda. now owns 31,179 shares of the technology company's stock worth $9,217,000 after purchasing an additional 7,179 shares in the last quarter. Institutional investors own 67.38% of the company's stock.
Celestica Company Profile
(
Get Free Report)
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.